EUVIMEDEUVIMED entdecken
Korrektur

Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”

Cancer · 15.03.2026 · 132 (6)

DOI: 10.1002/cncr.70347 ↗

Kurz gefasst

Korrektur in der Zeitschrift Cancer, online erschienen am 13.03.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”. Cancer, 132(6). https://doi.org/10.1002/cncr.70347

Vancouver

Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”. Cancer. 2026;132(6). doi:10.1002/cncr.70347

BibTeX
@article{euvimed2026,
  title = {Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {6},
  doi = {10.1002/cncr.70347}
}
Kostenlos starten →